In Brief: AMA on NSAIDs
This article was originally published in The Tan Sheet
AMA on NSAIDs: Consumers using OTC nonsteroidal anti-inflammatory drugs may be "placing themselves at risk for a catastrophic problem," including dyspepsia, mucosal lesions or ulcers, Michael Kimmey, MD, University of Washington, tells July 17 "media briefing" on pain held by the American Medical Association and sponsored by an Ortho-McNeil educational grant. According to Kimmey, 50% to 80% of people who go to hospitals for GI bleeding are taking NSAIDs. An AMA release notes that "there are other drugs for pain without gastrointestinal toxicity -- including acetaminophen." The Aspirin Foundation of America, in a same-day statement, argues that the program "appears to be one in a series of 'scientific' programs sponsored by Ortho-McNeil...which highlight purported adverse effects of analgesics that compete with Tylenol." The programs are an "important part" of the company's "marketing program for Tylenol," AFA maintains...
You may also be interested in...
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
Perrigo promotes in pricing, planning